A Phase I Study of Lenalidomide and Anti-GD2 Mab Ch14.18 +/- Isotretinoin in Patients With Refractory/Recurrent Neuroblastoma
Phase of Trial: Phase I
Latest Information Update: 20 Nov 2017
At a glance
- Drugs Lenalidomide (Primary) ; Dinutuximab; Isotretinoin
- Indications Neuroblastoma
- Focus Adverse reactions
- 07 Sep 2017 Status changed from recruiting to suspended due to Scheduled interim monitoring.
- 10 Apr 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
- 27 Aug 2015 Planned primary completion date changed from 1 Jul 2015 to 1 Dec 2016, as reported by ClinicalTrials.gov.